IRZ-01
Solid Tumors (Colorectal, Endometrial, Gastric cancers)
Pre-clinicalActive
Key Facts
Indication
Solid Tumors (Colorectal, Endometrial, Gastric cancers)
Phase
Pre-clinical
Status
Active
Company
About Irazu Oncology
Irazu Oncology is an early-stage biotech developing novel, off-the-shelf cancer immunotherapies based on engineered bacterial outer membrane vesicles (OMVs). The company's platform, derived from over 15 years of academic research, is designed for scalable manufacturing to lower costs and improve accessibility compared to personalized cell therapies. Led by a seasoned team with extensive drug development experience, Irazu's lead candidate, IRZ-01, targets multiple solid tumors and represents a potentially disruptive approach in the immuno-oncology space.
View full company profile